aratinga.bio

aratinga.bio
aratinga.bio
aratinga.bio is a preclinical stage company founded in March 2017 developing novel immunotherapies to treat cancer. The company is developing its proprietary CAR T-cell platform to be effective against hematological cancers and solid tumors as well, regardless of the type of treatments patients have experienced before.
Villejuif
Biotechnology
No funding announced yet
2017
http://www.aratinga.bio/
💡 You’re a corporate or investor and looking for startups that are innovating in the same market as aratinga.bio? We’re happy to assist you with our Startup Sourcing service.